SINGAPORE, SINGAPORE, Could 14th, 2024, Chainwire
Vyvo Good Chain, a HealthFi ecosystem that rewards well being monitoring by information monetization, right now introduced that Vyvo has obtained U.S. Meals and Drug Administration (FDA) clearance for LifeWatch, the corporate’s modern wearable machine for well being & wellness monitoring. This achievement marks a big leap ahead within the convergence of blockchain expertise and well being monitoring.
Vyvo’s LifeWatch pioneers a brand new period in well being and wellness. LifeWatch promotes a user-centric well being monitoring mannequin and leverages Decentralized Bodily Infrastructure community (DePIN) expertise to permit customers to monetize their well being information. This ensures privateness, anonymity, and full possession and management over private well being information, empowering customers to securely handle and monetize their data.
Fabio Galdi, Co-Founder and CEO of Vyvo, said, “This approval marks a big development in integrating blockchain expertise into well being and wellness. Our dedication is to innovation and person empowerment, and this FDA clearance positions us to proceed difficult the present norms and lead a metamorphosis in well being options.”
Vyvo not solely empowers customers with superior wellness monitoring instruments but in addition fosters a safe and clear ecosystem for well being information, powered by blockchain expertise. By regularly pushing the boundaries of digital well being administration, Vyvo opens up new avenues for people to take cost of their well-being.
Vyvo’s wearable units can be found at helohealth.com. To study extra about VSC and incomes rewards by well being monitoring, customers can go to vyvo.com.
About Vyvo Good Chain
Vyvo Good Chain is a HealthFi ecosystem that rewards well being monitoring by information monetization on IoT units. Vyvo makes it straightforward for folks to grasp and observe their physique stats, safe well being information privateness and earn rewards for doing so whereas contributing to analysis into new medicine, growing therapies, and stopping the unfold of ailments.
take away advertisements
.
ContactMike Evansmike@multipliedhq.com
This text was initially printed on Chainwire